Testicular cancer: Management challenges in an African developing country

South African Medical Journal

Volumn 100, Issue 7, 2010, Pages 452-455

  Ugwumba, F O ^a   Aghaji, A E ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; METHYLPREDNISOLONE; METOCLOPRAMIDE; SEROTONIN 3 ANTAGONIST; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPING COUNTRY; EMBRYONAL CARCINOMA; FOLLOW UP; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NIGERIA; ORCHIECTOMY; OUTCOME ASSESSMENT; PNEUMONIA; SCROTAL SWELLING; SEMINOMA; STOMATITIS; TESTIS CANCER; TUMOR LOCALIZATION; AFRICA; CHILD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TESTICULAR NEOPLASMS;

ADOLESCENT; ADULT; AFRICA; ANTINEOPLASTIC AGENTS; CARCINOMA, EMBRYONAL; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; DEVELOPING COUNTRIES; FOLLOW-UP STUDIES; HUMANS; LAPAROTOMY; MALE; MIDDLE AGED; ORCHIECTOMY; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 77954460705     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.3871     Document Type: Article

References (17)

1. Greenlee R, Murray T, Bolden S, et al. Cancer statistics 2000. CA Cancer J Clin 2000; 50(1): 7.
2. Dixon FJ, Moore RA. Tumors of the Male Sex Organs. Washington, DC: Armed Forces Institute of Pathology, 1952.
3. Templeton AC. Testicular neoplasms in Ugandan Africans. Afr J Med Sci 1972; 3(2): 157.
4. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumour Working Party. J Clin Oncol 1992; 10(11): 1762.
5. Sankarananarayanan R, Swaminathan R, Black RJ. Global variations in cancer survival. Cancer 1996; 78(12): 2461-2464.
6. Oliver RTD. Testicular cancer. Curr Opin Oncol 2001; 13(3): 191-198.
7. Cooper DE, L'esperance JO, Christman MS, Auge BK. Testis cancer: A 20-year epidemiological review of the experience at a regional military medical facility. J Urol 2008; 180(2): 577-581.
8. Mushtaq S, Jamal S, Mamoon N, Akbar N, Khadim T. The pathological spectrum of testicular tumours in northern Pakistan. J Pak Med Assoc 2007; 57(10): 499-501.
9. Magoha GA. Testicular cancer in Nigerians. East Afr Med J 1995; 72(9): 554-556.
10. Opot EN, Magoha GA. Testicular cancer at Kenyatta National Hospital, Nairobi. East Afr Med J 2000; 77(2): 80-85.
11. Powles TB, Bhardwha J, Shamash J, Mandalia S, Oliver T. The changing presentation of germ cell tumours of the testes between 1983 and 2002. BJU Int 2005; 95: 1197-1200.
12. Bhardwha JM, Powles T, Berney D, Baithun S, Nargund VH, Oliver RTD. Assessing the size and stage of testicular tumours: 1984-2003. BJU Int 2005; 96: 819-821.
13. Pannek J, Pastor J, Haupt G, Voigtmann R, Senge T. Fear of risks of cure in the treatment of a giant germ cell tumour. Int Urol Nephrol 1996; 28(4): 553-557.
14. Anyanwu SNC, Temporal trends in breast cancer presentation in the third world. J Exp Clin Cancer Res 2008; 27: 17.
15. Ogunbiyi JO, Shittu OB, Aghadiuno PU, Lawani J. Seminoma arising in cryptorchid testes in Nigerian males. East Afr Med J 1996; 73(2): 129-132.
16. Aghaji AE, Mbonu OO, Bladder tumours in Enugu, Nigeria. Br J Urol 1989; 64(4): 399-402.
17. Porcaro AB, Antoniolli SZ, Schiavone D, Maffei N, Bassetto MA, Curti P. Management of clinical stage 1 pure seminoma. Report on 42 patients and review of the literature. Arch Ital Urol Androl 2002; 74(2): 77-80.